Measurement of an apoptotic product in the sera of breast cancer patients

European Journal of Cancer

Volumn 39, Issue 6, 2003, Pages 769-774

  Ueno, T ^a   Toi, M ^b   Biven K ^a   Bando, H ^b   Ogawa, T ^b   Linder, S ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Apoptosis; Breast cancer; Caspase; Cytokeratin 18; ELISA; M30; Serum

Indexed keywords

CASPASE; CYTOKERATIN 18; ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; APOPTOSIS; ARTICLE; BLOOD LEVEL; BREAST CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECURRENT CANCER;

EID: 0346035003     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00865-1     Document Type: Article

References (16)

1. Caulin C., Salvesen G.S., Oshima R.G. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J. Cell. Biol. 138:1997;1379-1394.
2. Ku N.O., Liao J., Omary M.B. Apoptosis generates stable fragments of human type I keratins. J. Biol. Chem. 272:1997;33197-33203.
3. MacFarlane M., Merrison W., Dinsdale D., Cohen G.M. Active caspases and cleaved cytokeratins are sequestered into cytoplasmic inclusions in TRAIL-induced apoptosis. J. Cell Biol. 148:2000;1239-1254.
4. Leers M.P., Björklund V., Kölgen W.et al. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J. Pathol. 187:1999;567-572.
5. Chiu P.M., Ngan Y.S., Khoo U.S., Cheung A.N. Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome. assessment by the caspase-related M30 CytoDeath antibody Histopathology. 38:2001;243-249.
6. Hägg M., Bivén K., Ueno T.et al. A novel high-through-put assay for screening of pro-apoptotic drugs. Invest. New Drugs. 20:2002;253-259.
7. Leon S.A., Shapiro B., Sklaroff D.M., Yaros M.J. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 37:1977;646-650.
8. Stroun M., Anker P., Lyautey J., Lederrey C., Maurice P.A. Isolation and characterization of DNA from the plasma of cancer patients. Eur. J. Cancer Clin. Oncol. 23:1987;707-712.
9. Johnson P.J., Lo Y.M. Plasma nucleic acids in the diagnosis and management of malignant disease. Clin. Chem. 48:2002;1186-1193.
10. Holdenrieder S., Stieber P., Forg T., Kuhl M., Schulz L., Busch M., Schalhorn A., Seidel D. Apoptosis in serum of patients with solid tumours. Anticancer Res. 19:1999;2721-2724.
11. Holdenrieder S., Stieber P., Bodenmuller H.et al. Nucleosomes in serum of patients with benign and malignant diseases. Int J Cancer. 95:2001;114-120.
12. Lipponen P., Aaltomaa S., Kosma V.M., Syrjanen K. Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur. J. Cancer. 14:1994;2068-2073.
13. de Jong J.S., van Diest P.J., Baak J.P. Number of apoptotic cells as a prognostic marker in invasive breast cancer. Br. J. Cancer. 82:2000;368-373.
14. Hannun Y.A. Apoptosis and the dilemma of cancer chemotherapy. Blood. 89:1997;1845-1853.
15. Meyn R.E., Stephens L.C., Ang K.K.et al. Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies. Int. J. Radiat. Biol. 64:1993;583-591.
16. Warri A.M., Huovinen R.L., Laine A.M., Martikainen P.M., Harkonen P.L. Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro. J. Natl. Cancer Inst. 85:1993;1412-1418.